ENGAGE BIOLOGICS INC.

Biotech · Acquired

Tethosome platform, a non-viral gene delivery system using mRNA-encoded DNA binding proteins and recombinant DNA vectors for transgene expression in target cells

Grants
$865K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
7
0 granted · 7 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Tethosomes: a non-viral DNA platform for durable expression of therapeutic transgenes in specific target cells$865,162
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2273INPHASOL INC.——
2274SYNVEST IMAGING INC.——
2275EdenRoc Sciences LLC—$194M
2276ENGAGE BIOLOGICS INC.——
2277Perfect Day, Inc.—$222M
2278Dren Bio, Inc.—$93M
2279CURAVAC, INC.—$4.7M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 7
  • Non-viral Expression Systems And Methods Of Use Thereofapplication
  • Non-viral Expression Systems Using A Lymphocryptovirus Dna Binding Protein And Methods Of Use Thereofapplication
  • Non-viral Expression Systems And Methods Of Use Thereofapplication
  • Non-viral Expression Systems And Methods Of Use Thereofapplication
  • Materials And Methods For Treatment With Mrna Encoding Multispecific Binding Moleculesapplication
  • Materials And Methods For Treatment With Mrna Encoding Multispecific Binding Moleculesapplication
  • Non-viral Expression Systems And Methods Of Use Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.